Veterinary Medicines

PARASSICID COLLARE 150 mg/g collare antiparassitario per cani e gatti

Authorised
  • Dimpylate
Download as PDF

Product identification

Medicine name:
PARASSICID COLLARE 150 mg/g collare antiparassitario per cani e gatti
PARASSICID COLLARE 150 mg/g collare antiparassitario per cani e gatti
Active substance:
  • Dimpylate
Target species:
  • Dog (large)
  • Dog (medium)
  • Dog (small)
  • Cat
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Dimpylate
    150.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Collar
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog (large)
      • Unspecified
        0
        day
    • Dog (medium)
      • Unspecified
        0
        day
    • Dog (small)
      • Unspecified
        0
        day
    • Cat
      • Unspecified
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AF03
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Available in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Formevet S.r.l.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratoires Biové
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 103230
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 19/09/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."